send to a friend by email

JPH achieves net income of $1.61 million in 9M 2013

2013-10-30

According to Jerusalem Pharmaceuticals Company ( JPH)’s data for the first nine months of the year, net profit after taxes reached 1,609,305 USD, compared with a net loss of (256,458) USD from the first nine months of 2012. Total assets of the company reached 52,801,545 USD as of September 30^th, 2013, compared to total assets of 48,875,519 USD as of December 31^st, 2012, a net increase of 8.0%. Total liabilities of the company reached 16,149,981 USD as of September 30^th, 2013, compared to total liabilities of 15,164,803 USD as of December 31^st, 2012, a net increase of 6.5%. Net ownership equity of the company reached 36,651,564 USD (including 780,977 USD in Minority Rights) as of September 30^th, 2013, compared with a net ownership equity of 33,710,716 USD (including 951,501 USD in Minority Rights) as of December 31^st, 2012, a net increase of 8.7% in the first nine months. Furthermore, paid-in capital increased from 8,530,000 USD on December 31^st, 2012 to 17,060,000 USD  by September 30^th, 2013, an increase of 100.0%.